An Investigator participating in a clinical trial is responsible for protecting the rights, safety, and welfare of trial participants. Part of this responsibility is:A. Ensuring all subjects are consented appropriately and documented using the IRB approved Informed Consent form.B. Making sure that target enrollment goals are met.C. Enrolling subjects into the study who meet the exclusion criteria.D. Ensuring that the names of all subjects participating in the study are available to the general public.

The investigator's responsibility in a clinical trial primarily revolves around the protection of the rights, safety, and welfare of the trial participants. This includes:

A. Ensuring all subjects are consented appropriately and documented using the IRB approved Informed Consent form. This is a crucial step as it ensures that all participants are fully aware of the trial, its potential risks and benefits, and their rights as participants. It also provides a record that the participant has agreed to take part in the trial.

B. Making sure that target enrollment goals are met is not a primary responsibility of the investigator. While it is important for the success of the trial, the investigator's main focus should be on the safety and welfare of the participants.

C. Enrolling subjects into the study who meet the exclusion criteria is not a responsibility of the investigator. In fact, it is the opposite. The investigator should ensure that only those who meet the inclusion criteria and none of the exclusion criteria are enrolled in the trial.

D. Ensuring that the names of all subjects participating in the study are available to the general public is not a responsibility of the investigator. In fact, this would be a breach of confidentiality and a violation of the participant's privacy rights. The identity of participants in a clinical trial should be kept confidential unless the participant has given explicit consent for their identity to be disclosed.

The investigator's responsibility in a clinical trial primarily involves protecting the rights, safety, and welfare of the trial participants. This includes:

A. Ensuring all subjects are consented appropriately and documented using the IRB approved Informed Consent form. This is a crucial step as it ensures that all participants are fully aware of the trial, its potential risks and benefits, and their rights as participants. It also provides a record that the participant has given their informed consent to participate.

B. Making sure that target enrollment goals are met is not a primary responsibility of the investigator. While it is important for the success of the trial, the investigator's main focus should be on the safety and welfare of the participants.

C. Enrolling subjects into the study who meet the exclusion criteria is not a responsibility of the investigator. In fact, doing so could potentially harm the participant and compromise the integrity of the trial. The investigator should only enroll participants who meet the inclusion criteria and do not meet the exclusion criteria.

D. Ensuring that the names of all subjects participating in the study are available to the general public is not a responsibility of the investigator. In fact, this would be a breach of confidentiality and a violation of the participant's privacy rights. The identity of participants in a clinical trial should be kept confidential and only disclosed with the participant's consent or as required by law.